A new says rising obesity rates will continue to be an increasing burden on the health care system over the next decade.
A new study predicts that rising obesity rates will continue to be an increasing burden on the health care system over the next decade. The report, "The Future Cost of Obesity: National and State Estimates of the Impact of Obesity on Direct Health Care Expenses," estimates obesity prevalence and costs at the state and national level 10 years from now.
Based on research by Emory University healthcare economist Ken Thorpe, executive director of the Partnership to Fight Chronic Disease (PFCD), the report was commissioned by UnitedHealth Foundation, Partnership for Prevention, and American Public Health Association in conjunction with their annual America's Health Rankings report.
The new data predicts that if current trends continue, 43% of U.S. adults will be obese and obesity spending will quadruple to $344 billion by 2018. However, if obesity rates are held at current levels, the U.S. would save nearly $200 billion in health care costs, according to the report.
"Because obesity is related to the onset of so many other illnesses, stopping the growth of obesity in the U.S. is vital not only to our health - but also to the solvency of our health care system," said Thorpe.
The report projects that obesity will surpass 50% of the adult population in Kentucky, Maryland, Mississippi, Ohio, Oklahoma and South Dakota, with an associated increase in health spending linked to obesity of more than $1,600 per person in each of those states. The report also projects that obesity rates will remain below 35% in Colorado, Connecticut, Massachusetts, Virginia and the District of Columbia. Obesity-attributable health spending will climb to more than $800 per person by 2018 in each of those states, according to the report.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More